IRCT20210614051574N8 IRCT 2022-02-15 Esfahan University of Medical Sciences Nasal dexmedetomidine and oral chloral hydrate during electroencephalogram Comparative study of the effect of nasal dexmedetomidine and oral chloral hydrate on pediatric sedation during electroencephalogram 2022-03-05 anticipated 64 Complete https://irct.ir/trial/61860 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 2-3 Electroencephalogram. Intervention 1: Intervention group 1: Patients in this group, before the intervention, recieve intranasal dexmedetomidine from Abu Reihan company with dosage of 2-3 micrograms per kilogram and 10 minutes before the procedure. Patients will be monitored by the Pediatric Anesthesia Fellowship during the electroencephalogram, and information about patients' heart rate, blood pressure before and during the procedure will be monitored and recorded every 5 minutes.For each patient, the sleep onset latency is also recorded. Intervention 2: Intervention group 2: Patients in this group will receive 5% chloral hydrate syrup at a dose of 50-100 mg per kg orally 10 minutes before the procedure before the intervention. Patients will be monitored by the Pediatric Anesthesia Fellowship during the electroencephalogram, and information about patients' heart rate, blood pressure before and during the procedure will be monitored and recorded every 5 minutes.For each patient, the sleep onset latency is also recorded. Yes - There is a plan to make this available What will be shared: All data can be shared after people have requested. When: Six months after publishing the results. To whom: Academic researchers Conditions: Scientific uses Where to obtain: Website of the Research Committee of Isfahan University of Medical Sciences How to obtain: Clear request on the site to access the data by the individual and then review the request by the research assistant within 2 weeks and then allow access to the data. Comments: